Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial

被引：0
|
作者：
Xiao, Chunyan [1 ]
Ding, Yao [1 ]
Zeng, Chensi [1 ]
Zhang, Lingqian [1 ]
Guo, Bingling [1 ]
Nan, Yingyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Canc Hosp, Dept Hematol Oncol, Chongqing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181337
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
    Izutsu, Koji
    Makita, Shinichi
    Nosaka, Kisato
    Yoshimitsu, Makoto
    Utsunomiya, Atae
    Kusumoto, Shigeru
    Morishima, Satoko
    Tsukasaki, Kunihiro
    Kawamata, Toyotaka
    Ono, Takaaki
    Rai, Shinya
    Katsuya, Hiroo
    Ishikawa, Jun
    Yamada, Hironori
    Kato, Kazunobu
    Tachibana, Masaya
    Kakurai, Yasuyuki
    Adachi, Nobuaki
    Tobinai, Kensei
    Yonekura, Kentaro
    Ishitsuka, Kenji
    BLOOD, 2023, 141 (10) : 1159 - 1168
  • [42] Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
    O'Donnell, Elizabeth
    Mo, Clifton
    Yee, Andrew J.
    Nadeem, Omar
    Laubach, Jacob
    Rosenblatt, Jacalyn
    Munshi, Nikhil
    Midha, Shonali
    Cirstea, Diana
    Chrysafi, Pavlina
    Horick, Nora
    Richardson, Paul G.
    Raje, Noopur
    LANCET HAEMATOLOGY, 2024, 11 (06): : e415 - e424
  • [43] Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial
    Doorduijn, Jeanette K.
    Zijlstra, Josee M.
    Lugtenburg, Pieternella J.
    Kersten, Marie Josee
    Bohmer, Lara H.
    Minnema, Monique C.
    MacKenzie, Marius A.
    Kooij, Rien van Marwijk
    de Jongh, Eva
    Snijders, Tjeerd J. F.
    de Weerdt, Okke
    van Gelder, Michel
    Hoogendoorn, Mels
    Leys, Rineke B. L.
    Kibbelaar, Robby E.
    de Jong, Daphne
    Chitu, Dana A.
    Van't Veer, Mars B.
    Kluin-Nelemans, Hanneke C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : 385 - 393
  • [44] Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/TCell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase. Clinical Trial
    Gao, Yan
    Huang, Huiqiang
    Wang, Xiaoxiao
    Bai, Bing
    Huang, Yunhong
    Yang, Haiyan
    Zhang, QingYuan
    Li, Yufu
    Li, Yan
    Zhou, Min
    Yang, Runxiang
    Xu, Bing
    Liu, Lihong
    Yang, Yu
    Peng, Zhigang
    Yu, Ding
    Zhou, Hui
    Zhang, Rong Yan
    Zhang, Huilai
    Qi, Junyuan
    Xi, Yaming
    Xing, Xiaojing
    Wang, Zhao
    Jing, Hongmei
    Zhang, Xiaohong
    Ma, Liping
    Jin, Hongyan
    Yao, Hongxia
    Shuang, Yuerong
    Xia, Xuefang
    Xue, Jianfei
    Li, Chunlei
    BLOOD, 2020, 136
  • [45] High Rates of Remission with the Initial Treatment of Oral Selinexor Plus CHOP for Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes Analysis of a Multi-Center Phase II Study in China
    Ding, Kaiyang
    Ma, Jie
    Zhang, Xiaohui
    Wang, Chunling
    Huang Hongming
    Sheng, Lixia
    Liu, Hailing
    Cao, Lei
    Wu, Wei
    Li, Jianyong
    Fan, Lei
    BLOOD, 2023, 142
  • [46] Impact of Front-Line Treatment Interim PET/CT in Peripheral T-Cell Lymphoma Patients' Survival: Experience of a Single Center
    Rampi, Nicolo
    Cortes-Romera, Montserrat
    Lopez-Pereira, Patricia
    Martinez-Ramos, Carolina
    Montane Carbo, Clara
    Arevalo Leon, Carolina Esther
    De Oliveira, Ana C.
    Gonzalez Barca, Eva Maria
    Sureda Balari, Anna Maria
    Domingo Domenech, Eva
    BLOOD, 2023, 142
  • [47] High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study
    Ruan, Jia
    Moskowitz, Alison J.
    Mehta-Shah, Neha
    Sokol, Lubomir
    Chen, Zhengming
    Rahim, Riyaad
    Song, Wei
    Kotlov, Nikita
    Nos, Grigorii
    Maksimov, Vladislav
    Revuelta, Maria Victoria
    Sboner, Andrea
    Sigouros, Michael
    Besien, Koenvan
    Horwitz, Steven M.
    Rutherford, Sarah C.
    Mulvey, Erin C.
    Coleman, Morton
    Melnick, Ari
    Elemento, Olivier
    Inghirami, Giorgio
    Leonard, John P.
    Martin, Peter
    Cerchietti, Leandro
    BLOOD, 2021, 138
  • [48] Sintilimab for Relapsed/Refractory Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial (ORIENT-4)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 13 - 14
  • [49] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
    Makker, Vicky
    Rasco, Drew
    Vogelzang, Nicholas J.
    Brose, Marcia S.
    Cohn, Allen L.
    Mier, James
    Di Simone, Christopher
    Hyman, David M.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Schmidt, Emmett V.
    Guo, Matthew
    Sachdev, Pallavi
    Shumaker, Robert
    Aghajanian, Carol
    Taylor, Matthew
    LANCET ONCOLOGY, 2019, 20 (05): : 711 - 718
  • [50] Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
    DiNardo, Courtney D.
    Schuh, Andre C.
    Stein, Eytan M.
    Montesinos, Pau
    Wei, Andrew H.
    de Botton, Stephane
    Zeidan, Amer M.
    Fathi, Amir T.
    Kantarjian, Hagop M.
    Bennett, John M.
    Frattini, Mark G.
    Martin-Regueira, Patricia
    Lersch, Frederik
    Gong, Jing
    Hasan, Maroof
    Vyas, Paresh
    Doehner, Hartmut
    LANCET ONCOLOGY, 2021, 22 (11): : 1597 - 1608
12345